-
Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection
26 Feb 2013 12:04 GMT
… ESAs in patients with cancer, increased risk for death … recurrence in patients with cancer receiving ESAs.In controlled … patients receiving treatment for cancer and whose anemia is … information on Affymax, please visit www.affymax.com.Affymax Forward-Looking …
-
Supercharging conventional monoclonal antibodies
29 Jul 2024 09:08 GMT
… mechanism of action for treating cancer and autoimmune diseases?
Commit’s … -class therapeutics for patients with cancer and autoimmune diseases?
The BiCE … Equillium, Raptor Pharmaceuticals, CytomX Therapeutics, Affymax, and Amgen. Most recently, Krishna …
-
Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors
07 May 2024 12:11 GMT
… -resistant cancers, and prior, as President and Chief Executive Officer of Affymax …
-
Chemotherapy-Induced Anemia Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), | DelveInsight
22 Mar 2024 07:30 GMT
… attributed to head and neck cancers during this period. These projections … Cadila, FibroGen, Johnson & Johnson, Affymax, Chugai Pharmaceutical, Hoffmann-La Roche … -related condition among individuals with cancer is anemia. Chemotherapy-Induced Anaemia …